Endometrial Carcinoma — Research

Endometrial Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	36,288	`("Endometrial Carcinoma"[tiab] OR "UCEC"[tiab] OR "Endometrial Cancer"[tiab] OR "Carcinoma of Endometrium"[tiab] OR "Carcinoma of the Endometrium"[tiab] OR "CARCINOMA, ENDOMETRIAL, MALIGNANT"[tiab] OR "Uterine Corpus Endomential Carcinoma"[tiab])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	12,216	`("Endometrial Carcinoma"[tiab] OR "UCEC"[tiab] OR "Endometrial Cancer"[tiab] OR "Carcinoma of Endometrium"[tiab] OR "Carcinoma of the Endometrium"[tiab] OR "CARCINOMA, ENDOMETRIAL, MALIGNANT"[tiab] OR "Uterine Corpus Endomential Carcinoma"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	2,611	`("Endometrial Carcinoma"[tiab] OR "UCEC"[tiab] OR "Endometrial Cancer"[tiab] OR "Carcinoma of Endometrium"[tiab] OR "Carcinoma of the Endometrium"[tiab] OR "CARCINOMA, ENDOMETRIAL, MALIGNANT"[tiab] OR "Uterine Corpus Endomential Carcinoma"[tiab]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 18 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (14)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–14 of 14 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.
· Am J Obstet Gynecol · 2005 · PMID 15746676 · validated civic_curation pubmed
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.
· PLoS One · 2014 · PMID 24587245 · validated civic_curation pubmed
Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.
· Target Oncol · 2013 · PMID 23238879 · validated civic_curation pubmed
Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu.